Abstract

Abstract Disclosure: B.W. Sneddon: None. P.A. Friedman: None. T. Mamonova: None. The Na+-dependent NPT2A (SLC34A1) phosphate co-transporter is a major regulator of phosphate homeostasis. Its most notable structural element is a carboxy-terminal PDZ ligand that binds Na+/H+ Exchanger Regulatory Factor-1 (NHERF1, SLC9A3R1), a multidomain PDZ protein that determines apical NPT2A localization and is required for phosphate transport. NPT2A also possesses an uncharacterized internal PDZ ligand. Two recent clinical reports describe congenital hypophosphatemia in children harboring Arg495His or Arg495Cys variants within the internal PDZ motif. Wild-type internal 494TRL496 PDZ binds NHERF1 PDZ2, which we consider a regulatory domain. Ablating the internal PDZ ligand with a 494AAA496 variant blocked hormone-sensitive phosphate transport. Complementary approaches, including CRISPR/Cas9 technology, side-directed mutagenesis, confocal microscopy, and modeling, showed that NPT2A Arg495 His or Arg495Cys variants do not support PTH or FGF23 action on phosphate transport. CoIP experiments indicate that both variants bound NHERF1 similarly to WT NPT2A. However, in contrast to WT NPT2A, NPT2A Arg495His or Arg495Cys variants remain at the apical membrane and are not internalized in response to PTH. We predict that His or Cys substitution of the charged Arg495 changes the electrostatics, preventing phosphorylation of the upstream Thr494, interfering with phosphate uptake in response to hormone action, and inhibiting NPT2A trafficking. We advance a model where the carboxy-terminal PDZ ligand defines apical localization of NPT2A, while the internal PDZ ligand is essential for hormone-triggered phosphate transport. Presentation: Thursday, June 15, 2023

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call